Insider Buying: Neonc Technologies (NASDAQ:NTHI) CEO Buys $38,600.00 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 10,000 shares of the business’s stock in a transaction dated Monday, November 9th. The shares were bought at an average price of $3.86 per share, with a total value of $38,600.00. Following the purchase, the chief executive officer directly owned 3,263,000 shares of the company’s stock, valued at approximately $12,595,180. The trade was a 0.31% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Neonc Technologies Stock Up 3.4%

Shares of NASDAQ NTHI opened at $4.52 on Thursday. The stock has a fifty day moving average price of $3.30 and a 200 day moving average price of $5.31. Neonc Technologies Holdings, Inc. has a 1-year low of $2.50 and a 1-year high of $12.00.

Neonc Technologies (NASDAQ:NTHI) last announced its quarterly earnings data on Thursday, November 5th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.03).

Wall Street Analyst Weigh In

Several analysts have recently weighed in on NTHI shares. Wall Street Zen raised shares of Neonc Technologies from a “sell” rating to a “hold” rating in a report on Saturday, November 7th. Weiss Ratings cut shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, October 21st. Zacks Research raised shares of Neonc Technologies from a “strong sell” rating to a “hold” rating in a report on Thursday, November 5th. Roth Capital started coverage on shares of Neonc Technologies in a research report on Thursday, September 24th. They issued a “buy” rating for the company. Finally, BTIG Research reaffirmed a “buy” rating and issued a $15.00 price objective on shares of Neonc Technologies in a report on Tuesday, September 8th. Four research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $16.00.

Institutional Investors Weigh In On Neonc Technologies

A number of hedge funds and other institutional investors have recently modified their holdings of NTHI. Global Retirement Partners LLC purchased a new stake in shares of Neonc Technologies during the 2nd quarter worth approximately $126,000. BlackRock Inc. purchased a new position in Neonc Technologies in the 2nd quarter valued at approximately $815,000. Westmount Partners LLC increased its stake in Neonc Technologies by 355.2% in the 2nd quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock valued at $893,000 after purchasing an additional 153,858 shares in the last quarter. Finally, Bank of America Corp DE acquired a new position in Neonc Technologies during the second quarter worth $1,017,000.

Neonc Technologies Company Profile

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.